HK1090303A1 - 文冠果的提取物和從提取物分離出的化合物的組成，功能和應用，以及它們的製備方法 - Google Patents

文冠果的提取物和從提取物分離出的化合物的組成，功能和應用，以及它們的製備方法

Info

Publication number
HK1090303A1
HK1090303A1 HK06112129.3A HK06112129A HK1090303A1 HK 1090303 A1 HK1090303 A1 HK 1090303A1 HK 06112129 A HK06112129 A HK 06112129A HK 1090303 A1 HK1090303 A1 HK 1090303A1
Authority
HK
Hong Kong
Prior art keywords
same
composition
methods
compounds isolated
xanthoceras sorbifolia
Prior art date
Application number
HK06112129.3A
Other languages
English (en)
Inventor
Pui-Kwong Chan
May Sung Mak
Yun Wang
Original Assignee
Pacific Arrow Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34467961&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1090303(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pacific Arrow Ltd filed Critical Pacific Arrow Ltd
Publication of HK1090303A1 publication Critical patent/HK1090303A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
HK06112129.3A 2003-10-09 2006-11-03 文冠果的提取物和從提取物分離出的化合物的組成，功能和應用，以及它們的製備方法 HK1090303A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50985103P 2003-10-09 2003-10-09
US53210103P 2003-12-23 2003-12-23
PCT/US2004/033359 WO2005037200A2 (en) 2003-10-09 2004-10-08 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof

Publications (1)

Publication Number Publication Date
HK1090303A1 true HK1090303A1 (zh) 2006-12-22

Family

ID=34467961

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06112129.3A HK1090303A1 (zh) 2003-10-09 2006-11-03 文冠果的提取物和從提取物分離出的化合物的組成，功能和應用，以及它們的製備方法

Country Status (10)

Country Link
US (1) US20090041877A1 (zh)
EP (1) EP1670491B1 (zh)
JP (1) JP4815558B2 (zh)
KR (1) KR101135824B1 (zh)
CN (1) CN101242850B (zh)
AU (1) AU2004281707B2 (zh)
CA (1) CA2541425C (zh)
HK (1) HK1090303A1 (zh)
NZ (1) NZ546138A (zh)
WO (1) WO2005037200A2 (zh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727561B2 (en) 2001-08-31 2010-06-01 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US7524824B2 (en) 2003-09-04 2009-04-28 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US7514412B2 (en) 2003-10-09 2009-04-07 Pacific Arrow Limited Anticancer biangeloyl saponins
US7262285B2 (en) 2003-10-09 2007-08-28 Pacific Arrow Limited Anticancer biangeloyl saponins
US8614197B2 (en) 2003-10-09 2013-12-24 Pacific Arrow Limited Anti-tumor compounds with angeloyl groups
US7488753B2 (en) 2003-10-09 2009-02-10 Pacific Arrow Limited Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
TWI454269B (zh) * 2003-12-23 2014-10-01 Pacific Arrow Ltd 由文冠果（ｘａｎｔｈｏｃｅｒａｓ ｓｏｒｂｉｆｏｌｉａ）單離之化合物、其製備方法以及其用途
WO2006002602A1 (fr) * 2004-07-07 2006-01-12 Baizhen Yang Compose d'extraits d'enveloppe et de tiges de fruits de xanthoceras sorbifolia, son procede de preparation et ses utilisations
US9382285B2 (en) 2004-09-07 2016-07-05 Pacific Arrow Limited Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
US8735558B2 (en) * 2005-02-14 2014-05-27 Pacific Arrow Limited Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
EP1811840B1 (en) * 2004-09-07 2016-04-13 May Sung Mak Anti-tumor compounds with angeloyl groups
WO2008133766A1 (en) * 2007-02-16 2008-11-06 Pacific Arrow Limited Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
US8586719B2 (en) 2005-04-27 2013-11-19 Pacific Arrow Limited Triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
CN100482254C (zh) * 2006-01-12 2009-04-29 哈尔滨三乐生物工程有限公司 文冠果子仁有效部位的提取方法
CN101553497B (zh) * 2006-09-01 2013-03-27 太平洋艾瑞有限公司 能抑止癌细胞生长的抗肿瘤化合物
US20100040758A1 (en) * 2006-12-28 2010-02-18 Chitra Vasant Savngikar Integrated production of phytochemical rich plant products or isolates from green vegetation
WO2011009032A1 (en) * 2009-07-16 2011-01-20 Pacific Arrow Limited Inhibiting the invasion and metastasis of cancer cells
US20120277308A1 (en) 2010-07-16 2012-11-01 Pacific Arrow Limited compounds for treating cancer and other diseases
US9499577B2 (en) 2009-07-16 2016-11-22 Pacific Arrow Limited Natural and synthetic compounds for treating cancer and other diseases
CN101948897B (zh) * 2010-09-11 2013-02-13 山西金绿禾燕麦研究所 从文冠果中提取文冠果油、文冠果多糖、文冠果水解蛋白肽的方法
KR101317368B1 (ko) * 2011-10-11 2013-10-11 이정택 조루증 치료용 한약 조성물
CN103242461A (zh) * 2012-02-06 2013-08-14 陕西理工学院 一种同时提取天麻多糖和天麻素的新方法
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis
CN103509077B (zh) * 2012-06-15 2015-08-05 沈阳药科大学 三萜皂苷类化合物及其制备方法和用途
CN102793647A (zh) * 2012-09-04 2012-11-28 山东理工大学 一种文冠果黄酮物质提取方法及其在抗衰老行业的应用
CN102796067A (zh) * 2012-09-04 2012-11-28 山东理工大学 一种文冠果壳中黄酮类物质提取方法
CN102813212A (zh) * 2012-09-04 2012-12-12 山东理工大学 文冠果黄酮在抗衰老领域的应用及其制备方法
CN102784087B (zh) * 2012-09-04 2014-05-28 山东理工大学 文冠果黄酮提取物在美白领域的应用及其提取方法
CN102783655B (zh) * 2012-09-04 2013-10-16 山东理工大学 文冠果黄酮提取物在减肥降脂领域的应用及其提取方法
CN103884731B (zh) * 2013-12-28 2016-09-28 丽珠集团利民制药厂 一种参芪扶正注射液核磁共振质量控制方法
WO2016157029A1 (en) * 2015-03-27 2016-10-06 Levius Vita Foods S.R.L. A process for the production of a phytoderivative
CN112341504A (zh) * 2015-12-21 2021-02-09 河北科技师范学院 一种有机溶剂浸提法提取葡萄籽中单宁的条件优化方法
CN105596257B (zh) * 2016-01-19 2018-07-27 杨凌普天农业科技有限公司 文冠果叶的抗氧化活性物、提取方法及在化妆品中的应用
CN107028175A (zh) * 2016-02-03 2017-08-11 苏州工业园区新国大研究院 马来樱桃叶提取物、其制备方法及其在制备能量缓释的食品中的应用
CN105707369A (zh) * 2016-02-05 2016-06-29 山西双林富农林开发有限公司 文冠果果柄保健茶及其制备方法、***
CN105693876B (zh) * 2016-02-17 2017-12-15 杨凌普天农业科技有限公司 文冠果叶多糖提取物、提取方法及其应用
CN105832601A (zh) * 2016-04-18 2016-08-10 山西双林富农林开发有限公司 一种从文冠果中提取表面活性剂的方法
CN105918551A (zh) * 2016-04-29 2016-09-07 山西双林富农林开发有限公司 文冠果果壳保健茶及其制备方法、***
CN106726785B (zh) * 2017-01-23 2019-09-20 杨凌普天农业科技有限公司 以文冠果油为基础油的护肤品
CN107897559A (zh) * 2017-11-23 2018-04-13 李现伟 一种蛋鸡饲料添加剂及蛋鸡饲料
CN107873959A (zh) * 2017-11-23 2018-04-06 李现伟 一种蛋鸡饲料添加剂及蛋鸡饲料
CN109999046B (zh) * 2019-05-20 2021-06-04 湖北中医药大学 一种茯苓寡糖及其制备方法和应用
CN110179814B (zh) * 2019-06-13 2022-09-16 安徽大学 一种蝉花虫草多糖、制备方法及在制备预防肾间质纤维化药物中应用
CN111166801B (zh) * 2019-12-31 2021-11-30 北京海达华环境科技有限公司 一种从文冠果鲜果壳中连续提取氨基酸、黄酮、皂苷、色素的方法
CN113549118B (zh) * 2021-06-23 2022-04-22 广东菁萃生物科技有限公司 一种高纯度三萜皂苷的提取方法及其应用
CN114736917B (zh) * 2022-03-27 2023-08-01 苏州大学 Usp11在抑制细胞因子il6降解中的应用
CN116179601B (zh) * 2023-03-22 2023-12-15 四川大学华西第二医院 一种构建具有社交障碍的自闭症疾病动物模型的方法及应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304124A1 (en) * 1997-09-17 1999-03-25 The Walter And Eliza Hall Institute Of Medical Research Bci-2-like protein bim and methods of use thereof
IN183330B (zh) * 1998-03-23 1999-11-20 Dalmia Ct For Biotechnology
CN1307473A (zh) * 1998-05-19 2001-08-08 研究发展基金会 三萜组合物和它们的使用方法
DE69918166T2 (de) * 1998-12-22 2005-07-07 Janssen Pharmaceutica N.V. Antiprotozoale saponine
US6541369B2 (en) * 1999-12-07 2003-04-01 Applied Materials, Inc. Method and apparatus for reducing fixed charges in a semiconductor device
AU7003101A (en) * 2000-06-22 2002-01-02 American Cyanamid Co Qs-21 and il-12 as an adjuvant combination
US7727561B2 (en) * 2001-08-31 2010-06-01 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US7524824B2 (en) * 2003-09-04 2009-04-28 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US6616943B2 (en) * 2001-08-31 2003-09-09 Fountain Silver Limited Composition comprising Wenguanguo extracts and methods for preparing same
CN1350001A (zh) 2001-10-31 2002-05-22 杨柏珍 可提取包括文冠果总皂甙、粗脂肪、粗蛋白、糖的果壳
CN100346805C (zh) * 2001-10-31 2007-11-07 杨柏珍 治疗脑功能低下、抗糖尿病活性的文冠果果壳提取物
US7488753B2 (en) * 2003-10-09 2009-02-10 Pacific Arrow Limited Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
US7262285B2 (en) * 2003-10-09 2007-08-28 Pacific Arrow Limited Anticancer biangeloyl saponins
US7514412B2 (en) * 2003-10-09 2009-04-07 Pacific Arrow Limited Anticancer biangeloyl saponins
US8614197B2 (en) * 2003-10-09 2013-12-24 Pacific Arrow Limited Anti-tumor compounds with angeloyl groups
US20060263458A1 (en) * 2003-10-09 2006-11-23 Mak May S Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US20060111310A1 (en) * 2003-10-09 2006-05-25 Chan Pui-Kwong Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
EP1677801A4 (en) * 2003-10-10 2010-09-22 Sk Chemicals Co Ltd EFFICIENT TRITERPENES TO IMPROVE BRAIN FUNCTIONS
GB0323965D0 (en) * 2003-10-13 2003-11-19 Glaxosmithkline Biolog Sa Immunogenic compositions
WO2006002602A1 (fr) * 2004-07-07 2006-01-12 Baizhen Yang Compose d'extraits d'enveloppe et de tiges de fruits de xanthoceras sorbifolia, son procede de preparation et ses utilisations
ES2395818T3 (es) * 2004-07-13 2013-02-15 Charite - Universitatsmedizin Berlin Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina
BRPI0514103B1 (pt) * 2004-08-04 2016-02-10 Reckitt Benckiser Inc dispostivo de distribuição
CN1754541A (zh) * 2004-09-30 2006-04-05 成都地奥制药集团有限公司 甾体皂苷药物组合物及其制备方法和用途
US20050209445A1 (en) * 2004-11-30 2005-09-22 Gokaraju Ganga R Process for producing enriched fractions containing upto 100% of bacoside a and bacoside b from plant materials of bacopa species
US20070196517A1 (en) * 2005-07-13 2007-08-23 Dictuc S.A. Modified Saponin Molluscicide
US8048457B2 (en) * 2006-04-18 2011-11-01 Sartec Corporation Saponin and preservative compositions and methods
TW200823182A (en) * 2006-08-01 2008-06-01 Praecis Pharm Inc Chemical compounds
US7544668B2 (en) * 2006-11-17 2009-06-09 Hong Kong Baptist University Saponins derived from Ilex pubescens and method of purifying the same

Also Published As

Publication number Publication date
EP1670491B1 (en) 2015-07-29
WO2005037200A8 (en) 2005-09-01
WO2005037200B1 (en) 2005-10-06
JP2007508317A (ja) 2007-04-05
CN101242850A (zh) 2008-08-13
AU2004281707B2 (en) 2011-06-09
WO2005037200A2 (en) 2005-04-28
NZ546138A (en) 2009-12-24
CA2541425A1 (en) 2005-04-28
AU2004281707A1 (en) 2005-04-28
KR20060109893A (ko) 2006-10-23
JP4815558B2 (ja) 2011-11-16
US20090041877A1 (en) 2009-02-12
KR101135824B1 (ko) 2012-04-16
CN101242850B (zh) 2013-03-20
EP1670491A4 (en) 2009-11-11
CA2541425C (en) 2013-01-29
WO2005037200A3 (en) 2005-06-16
EP1670491A2 (en) 2006-06-21

Similar Documents

Publication Publication Date Title
HK1090303A1 (zh) 文冠果的提取物和從提取物分離出的化合物的組成，功能和應用，以及它們的製備方法
EP1708724A4 (en) COMPOSITION WITH XANTHOCERAS SORBIFOLIA EXTRACTS, INSULATED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USES
EP1646382A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
AU2003262747A8 (en) Compounds, compositions, and methods
EP1503993A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
HK1070656A1 (en) Compounds, compositions, and methods
AU2003270015A8 (en) Compounds, compositions, and methods
ZA200702131B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof l
IL172023A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2003299612A8 (en) Compounds, compositions and methods
IL176515A0 (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
IL172027A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL167936A0 (en) Compounds, compositions,and methods
EP1711527A4 (en) HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
AU2003290507A8 (en) Compounds, compositions and methods
EP1675834A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
AU2003277079A8 (en) Compounds, compositions, and methods
ZA200606542B (en) 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
EP1680420A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
EP1594849A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
EP1620092A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
AU2002953252A0 (en) Compositions, Compounds and Methods for their Preparation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201008